[Is hypolipemic treatment effective as a preventive measure?].
Rywik
S
S
D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D005060:Europe; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D006951:Hyperlipoproteinemias / Q000150:complications / Q000188:drug therapy*; D007391:International Cooperation; D008297:Male; D008875:Middle Aged
D008078:Cholesterol, LDL; D002792:Cholestyramine Resin; D002994:Clofibrate
Czy działanie hypolipemizujace jest efektywne w prewencji?